Wire · opportunities
Beckman Coulter Diagnostics Receives U.S. FDA Clearance for Rapid Bacterial vs. Viral ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 3 November 2026 · Fusion42 review
Beckman Coulter Diagnostics received U.S. FDA clearance for the Access MeMed BV assay, a rapid host-response blood test that distinguishes bacterial from viral infections in adults and children within 15 minutes. The assay integrates with existing immunoassay analyzers, aids timely treatment decisions, supports antibiotic stewardship, and has potential to reduce unnecessary antibiotic use and healthcare costs.
This Wire brief sits within Fusion42's coverage of Medtech, and 6 sources have reported it between 3 Nov 2026 and 4 Nov 2026.
◆ ◆ The Wire takeaway
You can now offer quick bacterial vs viral infection tests without new lab equipment, speeding up treatment choices and cutting needless antibiotic use. This opens a new clinical decision point for paediatric and adult care pathways you should prioritise this week.
◆ Coverage
6 sources · first reported 3 Nov 2026 · latest 4 Nov 2026
◆ Related on Wire
◆ Topics